BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE ...

Mytos, an innovative leader in automated cell manufacturing, has entered into a manufacturing collaboration with Aspen Neuroscience, Inc. to automate the manufacturing of autologous dopaminergic ...

BIAL has reported the completion of the full dose regimen for the first subject in the multicentre Phase II ACTIVATE trial of ...

Women's risk of Parkinson's is similar to men's - but they are much more likely to be misdiagnosed, with serious consequences ...

The following is a summary of “Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian ...

While tremors and slow movement are the main symptoms of Parkinson's disease, one early sign of the condition can be heard in ...

BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient ...

Researchers at the University of Arizona have shed light on a common and troubling side effect of long-term Parkinson’s ...

The following is a summary of “Pain in Parkinson's disease is impacted by motor complications, anxiety and sleep disturbances ...

A small study found that depression rates dropped after each dance class, with significant improvements that persisted for ...

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...